A Multicenter, Randomized, Doube-blind, Phase III Study to Evaluate the Efficacy and Safety of HCP2102 in Patients With Essential Hypertension

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/4DA518F7.svg?ark=w1%2F20260526%2F4DA518F7&value=id)](https://nobleid.org/work/w1/20260526/4DA518F7)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors